rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
17
|
pubmed:dateCreated |
2004-9-9
|
pubmed:abstractText |
Thalidomide has a variety of biological effects that vary considerably according to the species tested. We sought to establish whether differences in pharmacokinetics could form a basis for the species-specific effects of thalidomide.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5949-56
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15355928-Adult,
pubmed-meshheading:15355928-Aged,
pubmed-meshheading:15355928-Aged, 80 and over,
pubmed-meshheading:15355928-Angiogenesis Inhibitors,
pubmed-meshheading:15355928-Animals,
pubmed-meshheading:15355928-Area Under Curve,
pubmed-meshheading:15355928-Chromatography, High Pressure Liquid,
pubmed-meshheading:15355928-Chromatography, Liquid,
pubmed-meshheading:15355928-Female,
pubmed-meshheading:15355928-Humans,
pubmed-meshheading:15355928-Male,
pubmed-meshheading:15355928-Mass Spectrometry,
pubmed-meshheading:15355928-Mice,
pubmed-meshheading:15355928-Mice, Inbred C57BL,
pubmed-meshheading:15355928-Middle Aged,
pubmed-meshheading:15355928-Multiple Myeloma,
pubmed-meshheading:15355928-Rabbits,
pubmed-meshheading:15355928-Species Specificity,
pubmed-meshheading:15355928-Thalidomide
|
pubmed:year |
2004
|
pubmed:articleTitle |
Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients.
|
pubmed:affiliation |
Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|